Boston, MA -- (SBWIRE) -- 01/13/2016 -- Technavio's market research analyst predicts the global gastric cancer drugs market to grow rapidly at a CAGR of approximately 8% during the forecast period. The presence of huge unmet needs in the market is expected to result in this market's healthy growth during the forecast period. The presence of this high-unmet medical need will lead to an increased R&D of safe and effective drugs, which in turn will spur market growth during the estimated period.

The recent increase in the prevalence of gastric cancer due to lifestyle changes is expected to drive market growth. The sedentary lifestyle, excessive smoking, increased consumption of alcohol, and a rise in obesity are envisaged to result in the increased incidence of gastric cancer.

Get More Details on this Report and a Full Table of Contents at Global Gastric Cancer Drugs Market 2016-2020

Geographical segmentation and analysis of the gastric cancer drugs market

-Americas
-APAC
-Europe

In this market study, analysts have estimated the APAC region to account for the highest market share during the forecast period. Much of this region's growth can be attributed to the increasing demand for better healthcare infrastructure, which results in its massive market share of nearly 48% during the forecast period.

Competitive landscape and key vendors

The global gastric cancer drugs market is growing rapidly owing to the high proportion of individuals with gastric cancer and the presence of a strong drug pipeline. To gain traction in this market, the vendors are manufacturing and marketing gastric cancer drugs that exhibit a high safety and efficacy profile, this helps the vendors to gain a competitive edge over their peers.

The top vendors in the market are -

-Hoffmann-La Roche
-Eli-lilly
-Sanofi
-Otsuka Holdings

Other prominent vendors in the market include Novartis, Amgen, Boston Biomedical, AROG Pharmaceuticals, ARIAD Pharmaceuticals, Roche, Merck, Eli Lilly, AB Science, Galena Biopharma, AstraZeneca, Taiho Oncology, Samumed, Ipsen Biopharmaceuticals, Eddingpharm, Tekmira Pharmaceuticals, Bristol-Myers Squibb, Gilead Sciences, ASLAN Pharmaceuticals, Five Prime, Array Biopharma, BIND Therapeutics, Boehringer Ingelheim, Daiichi-Sankyo, Bayer HealthCare, and Celgene.

Key questions answered in the report include

-What will the market size and the growth rate be in 2020?
-What are the key factors driving the global gastric cancer drugs market?
-What are the key market trends impacting the growth of the gastric cancer drugs market?
-What are the challenges to market growth?
-Who are the key vendors in this market space?
-What are the market opportunities and threats faced by the vendors in the global gastric cancer drugs market?
-Trending factors influencing the market shares of the Americas, APAC, and Europe?
-What are the key outcomes of the five forces analysis of the gastric cancer drugs market?

Technavio also offers customization on reports based on specific client requirement.

Related report:

-Global Colorectal Cancer Drugs Market 2015-2019
-Global Colorectal Cancer Drugs Market 2015-2019
-Global Cancer Pain Therapeutics Market 2015-2019

Companies Mentioned in this Report: Hoffmann-La Roche, Eli-lilly, Sanofi, Otsuka Holdings, Novartis, Amgen, Boston Biomedical, AROG Pharmaceuticals, ARIAD Pharmaceuticals, Roche, Merck, Eli Lilly, AB Science, Galena Biopharma, AstraZeneca, Taiho Oncology, Samumed, Ipsen Biopharmaceuticals, Eddingpharm, Tekmira Pharmaceuticals, Bristol-Myers Squibb, Gilead Sciences, ASLAN Pharmaceuticals, Five Prime, Array Biopharma, BIND Therapeutics, Boehringer Ingelheim, Daiichi-Sankyo, Bayer HealthCare, Celgene.

About Fast Market Research
Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

Browse all Pharmaceuticals research reports at Fast Market Research

You may also be interested in these related reports:

-Global Colorectal Cancer Drugs Market 2015-2019
-PharmaPoint: Prostate Cancer - Global Drug Forecast and Market Analysis to 2023
-EpiCast Report: Gastric Cancer - Epidemiology Forecast to 2024
-PharmaPoint: HER2-Negative Breast Cancer - Global Drug Forecast and Market Analysis to 2023
-Intestinal Cancer Global Clinical Trials Review, H1, 2015